Apnimed, Inc. (APMD)
NASDAQ: APMD · Real-Time Price · USD
23.25
-1.62 (-6.51%)
Aug 12, 2026, 10:26 AM EDT - Market open
Apnimed Market Cap
Apnimed has a market cap or net worth of $925.89 million as of August 12, 2026.
Market Cap
925.89M
Enterprise Value
918.35M
1-Year Change
n/a
Ranking
Category
Stock Price
$23.25
ChartMarket Cap Chart
Since the IPO on July 31, 2026, Apnimed's market cap has increased from $607.99M to $925.89M, an increase of 52.29%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2026 | 925.89M | -6.51% |
| Aug 11, 2026 | 990.40M | -10.99% |
| Aug 10, 2026 | 1.11B | 3.48% |
| Aug 7, 2026 | 1.08B | -3.16% |
| Aug 6, 2026 | 1.11B | 5.17% |
| Aug 5, 2026 | 1.06B | 3.11% |
| Aug 4, 2026 | 1.02B | 2.84% |
| Aug 3, 2026 | 995.58M | 63.75% |
| Jul 31, 2026 | 607.99M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Corvus Pharmaceuticals | 1.17B |
| Inventiva | 1.16B |
| Cullinan Therapeutics | 1.14B |
| Alto Neuroscience | 1.11B |
| Lexicon Pharmaceuticals | 1.10B |
| Sana Biotechnology | 1.06B |
| Olema Pharmaceuticals | 1.05B |
| Odyssey Therapeutics | 1.01B |